• Could Death Receptor 5 Antibodies Make A Comeback?

    May 04 | Bio-IT World | Big pharma has invested billions of dollars in developing antibodies targeting death receptor 5 (DR5) over the years in hopes of improving the survival of patients with cancer. While promising when tested in mice in the lab, they invariably failed to show efficacy during phase 2 clinical studies. But researchers at the University of Virginia now have a new theory that could revive them. More
  • Sequencing Project for Developmental Differences, New Data Management Tools, Hyperscale Storage, More

    May 03 | Bio-IT World | NIH grant tackles COVID-19 disparities, St. Jude launches historic expansion, Illumina all in on African Pathogen Genomics Initiative, and new platforms and services to ease drug and vaccine development. Plus: new storage from VAST Data, and new solutions for tracking research papers and patents. More
  • Big Money for Gene Editing, Engineering, Structure-Based Drug Design, and Data Management

    Apr 29 | Bio-IT World | Illumina joins the Gates Foundation in a global pathogen genomics initiative, new money for immune profiling, and Benchling nets $200M for their cloud platform. More
  • Understanding Proteins With Natural Language Processing

    Apr 28 | Bio-IT World | New research from the departments of chemistry and physics at Cambridge University has just helped demonstrate the potential of natural language processing (NLP) for understanding biomolecular condensates. More
  • New Event Launching in June Focusing on AI for Pharmaceuticals

    Apr 26 | Bio-IT World | Bio-IT World and AI Trends are pleased to announce DECODE: AI for Pharmaceuticals, June 7-9, 2021, the first cross-functional conference to uncover AI’s true value for the pharmaceutical sector, while also focusing on data strategies, organizational change management, and implementation best practices. More
  • Why Prioritizing Genomic Research Is Critical for The Future of Healthcare

    Apr 23 | Bio-IT World | Over the past 20 years, the field of genomics has undergone significant progress and transformation. We are at an exciting juncture in this field; however, there is more to be done to ensure more equitable access to technologies and support researchers around the world. More
  • Bioinformatics Platform Designs Therapies Against Multi-Drug Resistant Bacteria

    Apr 22 | Bio-IT World | A Johns Hopkins University team has published details of their Facile Accelerated Specific Therapeutic (FAST) platform in Nature Communications Biology, a platform designed to address antibiotic resistance. More
  • How COVID-19 Is Changing the Sequencing Landscape

    Apr 20 | Bio-IT World | The pandemic has prompted diverse scientific groups to take on sequencing in the US—and for many, the new technology has brought additional challenges to overcome. But these NGS-newbies are learning and will change biology beyond COVID-19. More
  • COVID-19 Highlights the Need for Interoperability in Healthcare

    Apr 16 | Bio-IT World | In healthcare, the primary means of collecting patient data, the electronic health record (EHR), is one of the biggest offenders of a siloed approach to data. One need look no farther than the current pandemic to see how the lack of data-sharing infrastructure has prevented healthcare providers from getting a complete picture of their patients’ medical histories and hindered research on what treatments are working against the novel coronavirus. More
View more articles
Bio IT World Lead Gen

 
Industry-spotlight

Riffyn’s pioneering cloud system, Riffyn Nexus, delivers 2X faster development cycles and 4X productivity gains to the world’s most advanced scientific R&D organizations. Its process-centric experiment design, data capture, and data analytics overcome the limitations of ELN and LIMS systems. Its adaptive data integration engine delivers results that are always ready for machine learning.
Read more here!

Industry-spotlight

Digital Therapeutics: Taking digital health to a new level
Benchling is the most widely-adopted life sciences R&D cloud. Accelerate, measure, and forecast R&D – from discovery through bioprocessing – all in one place. It’s a fully unified platform that centralizes and standardizes all R&D data, so you can spend less time fighting with legacy software, and more time reaching breakthrough discoveries.
Read more here!